Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
|
March 1, 1987
A method for the classification of diabetes mellitus--diagnosis using scoring of clinical signs
M Kondo, T Sanke, K Nanjo, et al.
Internal Medicine (Tokyo, Japan)
|
November 6, 1998
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with deterioration during pregnancy
T Yanagawa, H Sakaguchi, T Nakao, et al.
Experimental Neurology
|
August 1, 1997
The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats
H Sasaki, K Naka, Y Kishi, et al.
Endocrine Journal
|
January 9, 1999
Characterization of the promoter of the mouse prohormone convertase PC2 gene
S Ohagi, H Tatsuta, T Sanke, et al.
Diabetes Research and Clinical Practice
|
December 1, 1995
Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes
K Naka, H Sasaki, Y Kishi, et al.
Diabetes Care
|
June 1, 1990
Lessons learned from molecular biology of insulin-gene mutations
D F Steiner, H S Tager, S J Chan, et al.
Radioisotopes
|
June 1, 1984
[Experimental and clinical evaluation of a pancreatic secretory trypsin inhibitor radioimmunoassay kit]
T Sanke, M Kondo, E Satogami, et al.
Diabetologia
|
February 1, 1991
Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients
T Sanke, T Hanabusa, Y Nakano, et al.
The American Journal of Pathology
|
December 7, 2000
S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin
S Sakagashira, H J Hiddinga, K Tateishi, et al.
Metabolism: Clinical and Experimental
|
July 28, 2001
The renal metabolism of insulin: urinary insulin excretion in patients with mutant insulin syndrome (insulin Wakayama)
T Hanabusa, C Oki, Y Nakano, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
|
March 1, 1987
A method for the classification of diabetes mellitus--diagnosis using scoring of clinical signs
M Kondo, T Sanke, K Nanjo, et al.
Internal Medicine (Tokyo, Japan)
|
November 6, 1998
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with deterioration during pregnancy
T Yanagawa, H Sakaguchi, T Nakao, et al.
Experimental Neurology
|
August 1, 1997
The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats
H Sasaki, K Naka, Y Kishi, et al.
Endocrine Journal
|
January 9, 1999
Characterization of the promoter of the mouse prohormone convertase PC2 gene
S Ohagi, H Tatsuta, T Sanke, et al.
Diabetes Research and Clinical Practice
|
December 1, 1995
Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes
K Naka, H Sasaki, Y Kishi, et al.
Diabetes Care
|
June 1, 1990
Lessons learned from molecular biology of insulin-gene mutations
D F Steiner, H S Tager, S J Chan, et al.
Radioisotopes
|
June 1, 1984
[Experimental and clinical evaluation of a pancreatic secretory trypsin inhibitor radioimmunoassay kit]
T Sanke, M Kondo, E Satogami, et al.
Diabetologia
|
February 1, 1991
Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients
T Sanke, T Hanabusa, Y Nakano, et al.
The American Journal of Pathology
|
December 7, 2000
S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin
S Sakagashira, H J Hiddinga, K Tateishi, et al.
Metabolism: Clinical and Experimental
|
July 28, 2001
The renal metabolism of insulin: urinary insulin excretion in patients with mutant insulin syndrome (insulin Wakayama)
T Hanabusa, C Oki, Y Nakano, et al.
Page
of 8